ArticleArchives of microbiology2026
Aloin of Aloe vera disrupts pseudomonas aeruginosa biofilm formation: exploring nutritional therapeutics.
Article in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pseudomonas aeruginosa is responsible for several infections due to its remarkable antibiotic resistance, facilitated by its ability to form biofilms. In this study, Aloin, an anthraquinone present in the plant Aloe vera, was tested for antibiofilm activity against P. aeruginosa PAO1. Aloin demonstrated efficient biofilm-inhibiting capacity at a sub-MIC dose of 4.8 mM, along with/without GEN at 0.002 µg/µL (sub-MIC), in an additive manner, determined by the FICI test. Furthermore, it reduced biofilm-associated carbohydrates by 66.9%, proteins by 66.22%, and extracellular DNA by 69.57%. In silico analysis revealed that Aloin interacts with key P. aeruginosa proteins, such as RhlI (Glide Score: -6.035 kcal/mol; Glide e-model score: -60.414 kcal/mol), LasI (Glide Score: -4.407 kcal/mol; Glide e-model score: -35.286 kcal/mol), LasR (chain A) (Glide Score: -3.764 kcal/mol; Glide e-model score: -36.012 kcal/mol), LasR (chain B) (Glide Score: -5.015 kcal/mol; Glide e-model score: -46.672 kcal/mol), PqsR (Glide Score: -4.701 kcal/mol; Glide e-model score: -25.491 kcal/mol), PelA (Glide Score: -6.097 kcal/mol; Glide e-model score: -53.723 kcal/mol), and PelB (Glide Score: -5.043 kcal/mol; Glide e-model score: -53.128 kcal/mol) by forming strong hydrogen bonds. In silico simulation studies also substantiated the Aloin-protein binding results. The production of virulence factors, such as exoprotease and pyocyanin, was reduced by 71% and 74%, respectively. Furthermore, CLSM and SEM analysis showed a decrease in biofilm thickness from 498 μm to 72 μm and a reduced denser structure in the presence of Aloin. These results suggest that Aloin from Aloe vera has the potential to be an effective biofilm inhibitor without toxicity, with broad applicability.
Indexed as
Identifiers
42406057What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.